We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

For decades, people in this area have been dealing with unusually high rates of serious health problems, such as multiple sclerosis, ulcerative colitis, Crohn’s disease, and various ...

Thousands of Scripps Health patients are still scrambling to find new medical care after Anthem and Scripps ceased their contract on Jan. 1.

Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Richard Allan Zeien, age 62 of New Hampton, passed away surrounded by his family on Sunday, Jan. 26, 2025, from complications of PSC (Primary Sclerosing Cholangitis) Liver Disease from ulcerative ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

2025 Q3 Financial Results (as of September 30, 2025) ...

Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...

Women with inflammatory bowel disease who delivered a twin gestation pregnancy had higher rates of preterm delivery and ...